Biomarker Feedback to Motivate Tobacco Cessation in Pregnant ALaska Native Women: Phase 2
MAW Phase 2
2 other identifiers
observational
39
1 country
1
Brief Summary
Use of tobacco is very high among Alaska Native pregnant women. The investigators are conducting a three phase study. The first study is nearly completed and involved measuring biomarkers of tobacco exposure in mothers and infants. The second phase of the research is a qualitative study to translate the biomarker findings to an intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 17, 2013
CompletedFirst Posted
Study publicly available on registry
December 23, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedDecember 19, 2017
December 1, 2017
1.7 years
December 17, 2013
December 15, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
receptivity to cancer risk messages
interview of participant reactions to biomarker findings
baseline
Secondary Outcomes (1)
confidant perceptions of cancer risk information
baseline
Eligibility Criteria
Alaska Native women and their confidants
You may qualify if:
- To be eligible the woman must:
- be Alaska Native
- be aged 18 years of age or older
- provide written informed consent
- have participated in Phase 1 of the research or is currently pregnant (\<= 24 weeks gestation)
- have used any tobacco product at least once in the past 7 days (cigarettes or both cigarettes/ST)
- To be eligible the confidant (he/she) must:
- be referred by the woman participant
- be aged 18 years of age or older
- provide written informed consent
You may not qualify if:
- \. does not provide written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
- Alaska Native Tribal Health Consortiumcollaborator
- University of California, San Franciscocollaborator
- University of Minnesotacollaborator
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Alaska Native Tribal Health Consortium
Anchorage, Alaska, 99577, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Psychology
Study Record Dates
First Submitted
December 17, 2013
First Posted
December 23, 2013
Study Start
December 1, 2013
Primary Completion
August 1, 2015
Study Completion
August 1, 2015
Last Updated
December 19, 2017
Record last verified: 2017-12